Skip to main content
. 2015 Dec 28;84(1):275–285. doi: 10.1128/IAI.01187-15

FIG 4.

FIG 4

Treatment with Nod1 and Nod2 agonists simultaneously in vitro increases C3GnT (A) and MUC2 (B) expression. Mucin-producing LS 174T cells were stimulated with a Nod1 agonist (C12-iE-DAP), a Nod2 agonist (L18-MDP), or both Nod1 and Nod2 agonists for investigation of C3GnT and MUC2. C3GnT and MUC2 expression was assessed by using real-time PCR. Data are represented as means, and error bars represent SEM. Groups were compared using Tukey's multiple comparison posttest. *, P < 0.05.